Have you been treated with Ixabepilone?

Breakthrough Breast Cancer is looking to hear from any breast cancer patients who have been treated with the chemotherapy drug Ixabepilone.

The National Institute for Health and Clinical Excellence (NICE) issues guidance on what medicines should be available in the NHS (known as technology appraisals). NICE are currently consulting on a technology appraisal to determine whether they should recommend the chemotherapy drug Ixabepilone for advanced or metastatic breast cancer.

If you have been treated with Ixabepilone, Breakthrough would be interested in hearing about your views regarding this treatment. To share your comments, please contact Georgina Downes via georginad@breakthrough.org.uk by September 12th, 2008.